Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01941706 · ClinicalTrials.gov registry record · NA

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

A NA study of Depression and Epilepsy, sponsored by Emory University.

Completed
Registry status
NA
Development phase
130
Enrollment target
4
Study locations

NCT01941706 is a NA study of Depression and Epilepsy that has completed, run by Emory University. The registered enrollment target is 130 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01941706, a NA study of Depression and Epilepsy, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
4
Study locations

Study Summary

Project UPLIFT, a home-based treatment for depression in people with epilepsy, was designed to be delivered to groups by telephone or Web. The Project UPLIFT intervention materials were demonstrated to be effective in treating depression among people with epilepsy in Georgia. This project will assess whether the materials are also effective for preventing depression among people with epilepsy, and will extend the project beyond Georgia to Michigan, Texas, and Washington.

Conditions Studied

Depression Epilepsy Depressive Symptoms Seizure Disorder

Interventions

  • BEHAVIORAL Project UPLIFT

Study Locations (4)

Georgia

  • Rollins School of Public Health - Atlanta

Michigan

  • University of Michigan - Ann Arbor

Texas

  • University of Texas Health Science Center - Houston

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2009-10
Est. Completion 2012-06
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01941706

The ClinicalTrials.gov registry entry for NCT01941706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Project UPLIFT is the first listed.

NCT01941706 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Michigan, Texas.

Frequently Asked Questions

What is clinical trial NCT01941706 about?

NCT01941706 is a clinical study titled "Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT". Project UPLIFT, a home-based treatment for depression in people with epilepsy, was designed to be delivered to groups by telephone or Web. The Project UPLIFT intervention materials were demonstrated to be effective in treating depression among people with epilepsy in Georgia. This project will asses...

What is the current status of trial NCT01941706?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2009-10. Estimated completion is 2012-06.

What conditions does trial NCT01941706 study?

This clinical trial studies the following conditions: Depression, Epilepsy, Depressive Symptoms, Seizure Disorder.

What interventions are being tested in trial NCT01941706?

The interventions under investigation include: Project UPLIFT (BEHAVIORAL).

Who is sponsoring clinical trial NCT01941706?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01941706 being conducted?

This trial has 4 study locations across Georgia, Michigan, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Epilepsy

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.